Company intelligence / Profile preview

NOWDiagnostics

Springdale, Arkansas, United Statesnowdx.com ↗

Ownership: Private
Employees: ~38
Development stage: Commercial

Overview

NOWDiagnostics has commercialized several rapid diagnostic tests, including an hCG pregnancy test in the US and Europe, cardiac and toxicology tests in Europe, and is developing additional assays for STDs, food intolerances, infectious diseases, and more. Their platform delivers results within minutes from a single drop of blood or saliva.

Therapeutic areas: Women's HealthOtherGastroenterologyCardiovascularInfectious Diseases
Modalities: DeviceDiagnostic test (rapid assay)
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

First To Know Syphilis Test

Commercial

Indications: Syphilis

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on NOWDiagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOWDiagnostics.

Explore the full profile